These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8649814)

  • 21. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent loss of chromosome 9 in human primary non-small cell lung cancer.
    Merlo A; Gabrielson E; Askin F; Sidransky D
    Cancer Res; 1994 Feb; 54(3):640-2. PubMed ID: 8306323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
    Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.
    Wistuba II; Behrens C; Virmani AK; Milchgrub S; Syed S; Lam S; Mackay B; Minna JD; Gazdar AF
    Cancer Res; 1999 Apr; 59(8):1973-9. PubMed ID: 10213509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
    Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
    Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Location of several putative genes possibly involved in human breast cancer progression.
    Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
    Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
    Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
    Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.
    Fujiwara Y; Emi M; Ohata H; Kato Y; Nakajima T; Mori T; Nakamura Y
    Cancer Res; 1993 Mar; 53(5):1172-4. PubMed ID: 8439963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
    Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
    Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
    Castells A; Gusella JF; Ramesh V; Rustgi AK
    Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.